Agilent Technologies
A
Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them
Managers holding
2
In their latest 13F (Q3 2026)
See who
Value held
$372m
Combined value at quarter end
Last quarter
1 bought
1 sold or trimmed
Price at Q2 ’26 end
$132.83
+16.5% in the quarter
Share price change by quarter
+14.5%Q3 ’24
-9.5%Q4 ’24
-12.5%Q1 ’25
+0.4%Q2 ’25
+8.8%Q3 ’25
+6.0%Q4 ’25
-16.2%Q1 ’26
+16.5%Q2 ’26
Managers holding it, by quarter
3Q4 ’23
3Q1 ’24
3Q2 ’24
3Q3 ’24
2Q4 ’24
2Q1 ’25
2Q2 ’25
2Q3 ’25
2Q4 ’25
2Q1 ’26
2Q2 ’26
0Q3 ’26
Who holds it
| Troy Asset Management | 9.9%$356m | Added +11% |
| Cantillon Capital Management | 2.5%$16.8m | Trimmed -95% |
Directors buying and selling
How this works
| Bought or sold | ||||
|---|---|---|---|---|
| 4 Sep 2026 | Dolsten MikaelDirector | ▼ Sold | 634 | $96k |
About the company
- Sector
- Technology · Laboratory Analytical Instruments
- Incorporated in
- Delaware
- Financial year ends
- 31 October
- Shares outstanding
- 282m at 26 Aug 2026
- SEC filings
- Annual reports and other filings on EDGAR
Revenue and profit
$3.9bnOct ’13
$4.0bnOct ’15
$4.5bnOct ’17
$5.2bnOct ’19
$6.3bnOct ’21
$6.8bnOct ’23
$6.9bnOct ’25
| Year | Revenue | Net income |
|---|---|---|
| Year to Oct 2025 | $6.9bn | $1.3bn |
| Year to Oct 2024 | $6.5bn | $1.3bn |
| Year to Oct 2023 | $6.8bn | $1.2bn |
| Year to Oct 2022 | $6.8bn | $1.3bn |
| Year to Oct 2021 | $6.3bn | $1.2bn |
| Year to Oct 2020 | $5.3bn | $719m |
| Year to Oct 2019 | $5.2bn | – |
| Year to Oct 2018 | $4.9bn | – |
| Year to Oct 2017 | $4.5bn | – |
| Year to Oct 2016 | $4.2bn | – |
| Year to Oct 2015 | $4.0bn | – |
| Year to Oct 2014 | $4.0bn | – |
| Year to Oct 2013 | $3.9bn | – |